In an effort to discover specific markers to isolate human hematopoietic stem cells, Jokubaitis and colleagues report that the monoclonal antibody BB9 reacts with hematopoietic cells displaying morphologic, phenotypic, and/or functional properties of stem and progenitor cells throughout human ontogeny.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1182/blood-2007-12-126672 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!